Cowden syndrome epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
 
(13 intermediate revisions by the same user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
 
{{Cowden syndrome}}
{{CMG}}; {{AE}} {{VKG}}
{{CMG}}; {{AE}} {{VKG}}
==Overview==
==Overview==
The [[incidence]] of rare disease [[cowden syndrome]] is approximately 1 in 250,000 individuals. The [[prevalence]] of [[cowden syndrome]] is unknown. The [[incidence]] of [[cowden syndrome]] increases with [[age]]. [[Cowden syndrome]] affects men and women equally.


==Epidemiology and Demographics==
==Epidemiology and Demographics==
Line 12: Line 13:
*The [[prevalence]] of [[cowden syndrome]] is unknown.<ref name="Bennett2010">{{cite journal|last1=Bennett|first1=Kristi L.|title=Germline Epigenetic Regulation of <emph type="ital">KILLIN</emph> in Cowden and Cowden-like Syndrome|journal=JAMA|volume=304|issue=24|year=2010|pages=2724|issn=0098-7484|doi=10.1001/jama.2010.1877}}</ref>
*The [[prevalence]] of [[cowden syndrome]] is unknown.<ref name="Bennett2010">{{cite journal|last1=Bennett|first1=Kristi L.|title=Germline Epigenetic Regulation of <emph type="ital">KILLIN</emph> in Cowden and Cowden-like Syndrome|journal=JAMA|volume=304|issue=24|year=2010|pages=2724|issn=0098-7484|doi=10.1001/jama.2010.1877}}</ref>
*The [[prevalence]] of [[breast cancer]] in [[cowden syndrome]] increases by 3 fold.<ref name="VargaPastore2009">{{cite journal|last1=Varga|first1=Elizabeth A|last2=Pastore|first2=Matthew|last3=Prior|first3=Thomas|last4=Herman|first4=Gail E|last5=McBride|first5=Kim L|title=The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly|journal=Genetics in Medicine|volume=11|issue=2|year=2009|pages=111–117|issn=1098-3600|doi=10.1097/GIM.0b013e31818fd762}}</ref>
*The [[prevalence]] of [[breast cancer]] in [[cowden syndrome]] increases by 3 fold.<ref name="VargaPastore2009">{{cite journal|last1=Varga|first1=Elizabeth A|last2=Pastore|first2=Matthew|last3=Prior|first3=Thomas|last4=Herman|first4=Gail E|last5=McBride|first5=Kim L|title=The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly|journal=Genetics in Medicine|volume=11|issue=2|year=2009|pages=111–117|issn=1098-3600|doi=10.1097/GIM.0b013e31818fd762}}</ref>
*The [[prevalence]] of [[Renal cell carcinoma|renal cell carcinomas]] in [[cowden syndrome]] increases by 2 fold.
*The [[prevalence]] of [[Renal cell carcinoma|renal cell carcinomas]] in [[cowden syndrome]] increases by 2 fold.<ref name="pmid189721962">{{cite journal |vauthors=Pilarski R |title=Cowden syndrome: a critical review of the clinical literature |journal=J Genet Couns |volume=18 |issue=1 |pages=13–27 |date=February 2009 |pmid=18972196 |doi=10.1007/s10897-008-9187-7 |url=}}</ref>
 
*The [[prevalence]] of non-medullary follicular [[thyroid cancer]] in [[cowden syndrome]] increases by 70 fold.<ref name="pmid21956414">{{cite journal |vauthors=Ngeow J, Mester J, Rybicki LA, Ni Y, Milas M, Eng C |title=Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations |journal=J. Clin. Endocrinol. Metab. |volume=96 |issue=12 |pages=E2063–71 |date=December 2011 |pmid=21956414 |pmc=3232626 |doi=10.1210/jc.2011-1616 |url=}}</ref><ref name="pmid219564142">{{cite journal |vauthors=Ngeow J, Mester J, Rybicki LA, Ni Y, Milas M, Eng C |title=Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations |journal=J. Clin. Endocrinol. Metab. |volume=96 |issue=12 |pages=E2063–71 |date=December 2011 |pmid=21956414 |pmc=3232626 |doi=10.1210/jc.2011-1616 |url=}}</ref>
===Case-fatality rate/Mortality rate===
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
*The case-fatality rate/mortality rate of [disease name] is approximately [number range].


===Age===
===Age===
*Patients of all age groups may develop [disease name].
*The [[incidence]] of [[cowden syndrome]] increases with [[age]].<ref name="pmid23158187">{{cite journal |vauthors=Milas M, Mester J, Metzger R, Shin J, Mitchell J, Berber E, Siperstein AE, Eng C |title=Should patients with Cowden syndrome undergo prophylactic thyroidectomy? |journal=Surgery |volume=152 |issue=6 |pages=1201–10 |date=December 2012 |pmid=23158187 |doi=10.1016/j.surg.2012.08.055 |url=}}</ref>
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
*Based on Surveillance Epidemiology and End Results (SEER) data the [[median]] [[age]] at [[diagnosis]] is before 35 years.<ref name="pmid18972196">{{cite journal |vauthors=Pilarski R |title=Cowden syndrome: a critical review of the clinical literature |journal=J Genet Couns |volume=18 |issue=1 |pages=13–27 |date=February 2009 |pmid=18972196 |doi=10.1007/s10897-008-9187-7 |url=}}</ref>
*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.  
*[Chronic disease name] is usually first diagnosed among [age group].
*[Acute disease name] commonly affects [age group].


===Race===
===Race===
*There is no racial predilection to [disease name].
*There is [[racial]] predilection to [[cowden syndrome]].
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
*[[Cowden syndrome]] usually affects individuals of the caucasians race more than other [[Race|races]].<ref name="LeeMoon1997">{{cite journal|last1=Lee|first1=H R|last2=Moon|first2=Y S|last3=Yeom|first3=C H|last4=Kim|first4=K W|last5=Chun|first5=J Y|last6=Kim|first6=H K|last7=Choi|first7=H S|last8=Kim|first8=D K|last9=Chung|first9=T S|title=Cowden's disease--a report on the first case in Korea and literature review|journal=Journal of Korean Medical Science|volume=12|issue=6|year=1997|pages=570|issn=1011-8934|doi=10.3346/jkms.1997.12.6.570}}</ref>
===Gender===
===Gender===
*[[Cowden syndrome]] affects men and women equally.<ref name="GuimarãesBranco2002">{{cite journal|last1=Guimarães|first1=Patrícia de Barros|last2=Branco|first2=Adeíza de Alencar|last3=Carvalho|first3=Elaine|last4=Lima|first4=Francisco Eduardo|last5=Almeida|first5=José Roberto|last6=Santos|first6=Josemir Belo dos|last7=Villa|first7=Luisa|last8=Rodrigues|first8=Sílvia Helena|last9=Siqueira|first9=Roberta|last10=De Perreli|first10=Tatiana|title=Síndrome de Cowden: relato de um caso|journal=Anais Brasileiros de Dermatologia|volume=77|issue=6|year=2002|pages=711–720|issn=0365-0596|doi=10.1590/S0365-05962002000600009}}</ref>
*[[Cowden syndrome]] affects men and women equally.<ref name="GuimarãesBranco2002">{{cite journal|last1=Guimarães|first1=Patrícia de Barros|last2=Branco|first2=Adeíza de Alencar|last3=Carvalho|first3=Elaine|last4=Lima|first4=Francisco Eduardo|last5=Almeida|first5=José Roberto|last6=Santos|first6=Josemir Belo dos|last7=Villa|first7=Luisa|last8=Rodrigues|first8=Sílvia Helena|last9=Siqueira|first9=Roberta|last10=De Perreli|first10=Tatiana|title=Síndrome de Cowden: relato de um caso|journal=Anais Brasileiros de Dermatologia|volume=77|issue=6|year=2002|pages=711–720|issn=0365-0596|doi=10.1590/S0365-05962002000600009}}</ref><ref name="MasmoudiChermi2011">{{cite journal|last1=Masmoudi|first1=Abderrahmen|last2=Chermi|first2=Zied Mohamed|last3=Marrekchi|first3=Slaheddine|last4=Raida|first4=Ben Salah|last5=Boudaya|first5=Sonia|last6=Mseddi|first6=Madiha|last7=Jalel|first7=Meziou Taha|last8=Turki|first8=Hamida|title=Cowden syndrome|journal=Journal of Dermatological Case Reports|volume=5|issue=1|year=2011|issn=1898-7249|doi=10.3315/jdcr.2011.1063}}</ref>
*Females are little more commonly affected by cowden syndrome than males. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
*Females are little more commonly affected by [[cowden syndrome]] than males.
 
===Region===
*The majority of [disease name] cases are reported in [geographical region].
 
*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
 
===Developed Countries===
 
===Developing Countries===


==References==
==References==

Latest revision as of 21:16, 22 February 2019

Cowden syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cowden Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cowden syndrome epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cowden syndrome epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cowden syndrome epidemiology and demographics

CDC on Cowden syndrome epidemiology and demographics

Cowden syndrome epidemiology and demographics in the news

Blogs on Cowden syndrome epidemiology and demographics

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Cowden syndrome epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]

Overview

The incidence of rare disease cowden syndrome is approximately 1 in 250,000 individuals. The prevalence of cowden syndrome is unknown. The incidence of cowden syndrome increases with age. Cowden syndrome affects men and women equally.

Epidemiology and Demographics

Incidence

Prevalence

Age

Race

Gender

References

  1. Nelen MR, Kremer H, Konings IB, Schoute F, van Essen AJ, Koch R, Woods CG, Fryns JP, Hamel B, Hoefsloot LH, Peeters EA, Padberg GW (April 1999). "Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations". Eur. J. Hum. Genet. 7 (3): 267–73. doi:10.1038/sj.ejhg.5200289. PMID 10234502.
  2. Eng, C. (2000). "Will the real Cowden syndrome please stand up: revised diagnostic criteria". Journal of Medical Genetics. 37 (11): 828–830. doi:10.1136/jmg.37.11.828. ISSN 1468-6244.
  3. Nelen MR, Padberg GW, Peeters EA, Lin AY, van den Helm B, Frants RR, Coulon V, Goldstein AM, van Reen MM, Easton DF, Eeles RA, Hodgsen S, Mulvihill JJ, Murday VA, Tucker MA, Mariman EC, Starink TM, Ponder BA, Ropers HH, Kremer H, Longy M, Eng C (May 1996). "Localization of the gene for Cowden disease to chromosome 10q22-23". Nat. Genet. 13 (1): 114–6. doi:10.1038/ng0596-114. PMID 8673088.
  4. Bennett, Kristi L. (2010). "Germline Epigenetic Regulation of <emph type="ital">KILLIN</emph> in Cowden and Cowden-like Syndrome". JAMA. 304 (24): 2724. doi:10.1001/jama.2010.1877. ISSN 0098-7484.
  5. Varga, Elizabeth A; Pastore, Matthew; Prior, Thomas; Herman, Gail E; McBride, Kim L (2009). "The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly". Genetics in Medicine. 11 (2): 111–117. doi:10.1097/GIM.0b013e31818fd762. ISSN 1098-3600.
  6. Pilarski R (February 2009). "Cowden syndrome: a critical review of the clinical literature". J Genet Couns. 18 (1): 13–27. doi:10.1007/s10897-008-9187-7. PMID 18972196.
  7. Ngeow J, Mester J, Rybicki LA, Ni Y, Milas M, Eng C (December 2011). "Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations". J. Clin. Endocrinol. Metab. 96 (12): E2063–71. doi:10.1210/jc.2011-1616. PMC 3232626. PMID 21956414.
  8. Ngeow J, Mester J, Rybicki LA, Ni Y, Milas M, Eng C (December 2011). "Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations". J. Clin. Endocrinol. Metab. 96 (12): E2063–71. doi:10.1210/jc.2011-1616. PMC 3232626. PMID 21956414.
  9. Milas M, Mester J, Metzger R, Shin J, Mitchell J, Berber E, Siperstein AE, Eng C (December 2012). "Should patients with Cowden syndrome undergo prophylactic thyroidectomy?". Surgery. 152 (6): 1201–10. doi:10.1016/j.surg.2012.08.055. PMID 23158187.
  10. Pilarski R (February 2009). "Cowden syndrome: a critical review of the clinical literature". J Genet Couns. 18 (1): 13–27. doi:10.1007/s10897-008-9187-7. PMID 18972196.
  11. Lee, H R; Moon, Y S; Yeom, C H; Kim, K W; Chun, J Y; Kim, H K; Choi, H S; Kim, D K; Chung, T S (1997). "Cowden's disease--a report on the first case in Korea and literature review". Journal of Korean Medical Science. 12 (6): 570. doi:10.3346/jkms.1997.12.6.570. ISSN 1011-8934.
  12. Guimarães, Patrícia de Barros; Branco, Adeíza de Alencar; Carvalho, Elaine; Lima, Francisco Eduardo; Almeida, José Roberto; Santos, Josemir Belo dos; Villa, Luisa; Rodrigues, Sílvia Helena; Siqueira, Roberta; De Perreli, Tatiana (2002). "Síndrome de Cowden: relato de um caso". Anais Brasileiros de Dermatologia. 77 (6): 711–720. doi:10.1590/S0365-05962002000600009. ISSN 0365-0596.
  13. Masmoudi, Abderrahmen; Chermi, Zied Mohamed; Marrekchi, Slaheddine; Raida, Ben Salah; Boudaya, Sonia; Mseddi, Madiha; Jalel, Meziou Taha; Turki, Hamida (2011). "Cowden syndrome". Journal of Dermatological Case Reports. 5 (1). doi:10.3315/jdcr.2011.1063. ISSN 1898-7249.

Template:WH Template:WS